China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

SHA:600062 Revenue

China Resources Double-Crane Pharmaceutical had revenue of 2.54B CNY in the quarter ending September 30, 2025, a decrease of -2.96%. This brings the company's revenue in the last twelve months to 10.95B, down -4.06% year-over-year. In the year 2024, China Resources Double-Crane Pharmaceutical had annual revenue of 11.21B, down -0.87%.

• Revenue (ttm): 10.95B
• Revenue Growth: -4.06%
• P/S Ratio: 1.82
• Revenue / Employee: 816.06K
• Employees: 13,414
• Market Cap: 19.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.21B	-98.52M	-0.87%
Dec 31, 2023	11.31B	1.68B	17.50%
Dec 31, 2022	9.63B	513.80M	5.64%
Dec 31, 2021	9.11B	607.58M	7.14%
Dec 31, 2020	8.50B	-877.05M	-9.35%